Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Bulletin from the Annual General Meeting of Metacon AB (publ)

Metacon AB (publ), reg. no. 556724-1616 (the "Company"), has held its Annual General Meeting on 12 June 2024 at Advokatfirman Schjødt at Hamngatan 27 in Stockholm. At the meeting, resolutions were made on the following. Adoption of the accounts and discharge from liabilityThe Annual General Meeting adopted the income statement and balance sheet for the Company and the Group for 2023. The members of the Board of Directors and the CEO were discharged from liability for the financial year 2023. Allocation of profitThe Annual General Meeting resolved, in accordance with the Board of

2.5 GW Mareld Floating Offshore Wind farm in Sweden receives positive recommendation from County Board

Mainstream Renewable Power ("Mainstream"), the pureplay global wind and solar company majority-owned by Aker Horizons ASA, announced that The County Administrative Board of Västra Götaland has proposed that the Government approve Freja Offshore's application to build the Mareld floating offshore wind farm, subject to certain adaptations.Freja Offshore is a 50-50 joint venture between Mainstream Renewable Power and Swedish company Hexicon. Freja Offshore welcomes the announcement, which is a crucial step in delivering the wind farm into commercial operation. Freja Offshore applied to

CS MEDICA Announces Strategic Partnership with OneMed

CS MEDICA Signs with OneMed for Enhanced Distribution and Marketing in DenmarkCS MEDICA is happy to announce a new strategic partnership with OneMed, a leading distributor in the healthcare sector. This collaboration marks a significant step in CS MEDICA's newly adopted B2B2C strategy, which focuses on generating strategic partnerships for enhanced market access while continuing to prioritize its core values in research and development, production, compliance, and insights. As part of the Asker Group, OneMed brings a robust distribution network and a deep understanding of the medical

Project update Vestmanna: Service and inspection of Dragon 12 - demonstration site attracting international study visits

Project Update Vestmanna: Four months of grid-connected operation with the utility-scale Dragon 12 is now followed by service and inspection. Ongoing operations continue to attract visits from international stakeholders and high-level decision-makers.After four months of grid-connected operation, the Dragon 12 was recovered successfully on the 6th of June for onshore inspection and maintenance program. This is the first inspection of the unit, covering all systems and components. The Dragon 12 will be reinstalled when these activities are completed.  One Dragon 4 unit has been installed

Inside information: Profit warning – Konecranes upgrades its profitability guidance for 2024

KONECRANES PLC INSIDE INFORMATION June 12, 2024 at 16:00 EEST   Inside information: Profit warning – Konecranes upgrades its profitability guidance for 2024   Konecranes upgrades its profitability guidance for 2024. During the first five months of the year, Konecranes’ strategy execution has progressed better than initially expected. The company has also continued its effective cost inflation management. As a result, Konecranes now expects its full-year 2024 comparable EBITA margin to improve from the previous year.   Konecranes updated financial guidance for 2024:

Getinge receives U.S. FDA 510(k) clearance for Talis +ACG Clinical Decision Support software, pioneering quality of high-acuity care in US and EU

Getinge has been granted U.S. FDA 510(k) clearance for its innovative clinical decision support software Talis +ACG (Advanced Clinical Guidance), steering in a new era of improving quality of care through promoting compliance with care protocols directly at the bedside in high acuity care environments. Global medtech company Getinge announces the U.S. FDA 510(k) clearance of its Talis +ACG clinical decision support software, including Talis-Anesthesia™, Talis-Perfusion™, Talis-RemoteView™, and Talis-ECMO™ applications. This milestone marks a significant leap forward in supporting

Bulletin from the Annual General Meeting 2024

Spectrumone AB’s Annual General Meeting was held on June 12, 2024 at Vasagatan 10 in Stockholm. Income statement and balance sheet The Annual General Meeting approved the income statement and balance sheet for the Parent Company and the Consolidated Income Statement and Consolidated Balance Sheet for the fiscal year of 2023. Disposal of profit/loss The Annual General Meeting decided that no dividend would be paid for the financial year 2023 and the loss for the year would be transferred as stated in the Annual report. Board The Annual General Meeting gave discharge for the

Repurchase of class C shares for incentive programs

The board of directors of Tobii AB (publ) (“Tobii”) today resolved to repurchase 794,429 outstanding class C shares. Today’s resolution by the board of directors was passed based on the authorisation granted by the annual general meeting held on May 23, 2024. Tobii will repurchase all outstanding C-shares at a purchase price corresponding to the quota value of SEK 0.007257 per share. The class C shares do not entitle to dividends and each share entitles to 1/10 voting right. The purpose of the repurchase is to enable potential future delivery of ordinary shares in accordance with the

Gaming Innovation Group - Issue of new shares

Gaming Innovation Group Inc. (“GiG” or the “Company”) has today issued 3,408,472 new shares of its common stock. The new shares are issued by the Board of Directors under the Company's 150,000,000 authorized shares, and the Company confirms that the new shares have been duly authorized by all necessary corporate actions and that the new shares have been fully paid and validly issued. The Company’s share capital has increased from USD 131,180,102 to USD 134,588,574, and the number of outstanding shares has increased from 131,180,102 to 134,588,574 (par value USD 1.00). In addition, a total

Tobii to utilize mandate to transfer shares

The Annual General Meeting of Tobii AB (publ) 2024 authorized the company's Board of Directors to resolve on the transfer of the company's own shares. The Board of Directors of Tobii has today resolved on the utilization of an authorization to transfer own shares. The shares may be transferred in order to, among other things, cover social contributions and costs for synthetic stock units under the company’s incentive program originally adopted at the annual general meeting in 2020, and to deliver ordinary shares to participants and to social contribution costs in relation to the company’s

Multiple contract awards in Brazil

Solstad Offshore ASA (Solstad) announces multiple contract awards from Petrobras, scheduled to commence in the second half of 2024 and first half of 2025. The combined gross contract value is approximately NOK 2,6 billion. Petrobras has contracted the CSV Normand Poseidon and the AHTSs Normand Sagaris and Normand Ferking, all owned by Solstad Maritime AS in which Solstad Offshore ASA holds a 31.6 percent ownership share. The Normand Poseidon has been awarded a four-year firm contract scheduled to commence in the third quarter of 2024 in continuation of its current charter with

Nokian Tyres plc: Shareholders' Nomination Board 2024

Nokian Tyres plc Stock Exchange Release June 12, 2024, at 3:00 p.m. EEST The following members have been appointed to Nokian Tyres’ Shareholders' Nomination Board: · Mr. Pauli Anttila (Investment Director, Solidium Oy), appointed by Solidium Oy · Mr. Mikko Mursula (Deputy CEO, Investments, Ilmarinen Mutual Pension Insurance Company), appointed by Ilmarinen Mutual Pension Insurance Company · Ms. Marie Karlsson (Chief Investment Officer, Nordic, Finnish and Swedish Equities at Nordea Asset Management) appointed by Nordea funds · Mr. Timo Sallinen (Director, Head of Listed

Decisions of Caverion Corporation’s Annual General Meeting and constitutive meeting of the Board of Directors

Caverion Corporation Stock Exchange Release 12 June 2024 at 14:45 EETDecisions of Caverion Corporation’s Annual General Meeting and constitutive meeting of the Board of DirectorsCaverion Corporation’s Annual General Meeting was held today on 12 June 2024 in Vantaa. The Annual General Meeting adopted the Financial Statements and the consolidated Financial Statements for the year 2023 and discharged the members of the Board of Directors and the CEO from liability. In addition, the Annual General Meeting resolved on the use of the profit shown on the balance sheet and the distribution of

BLAST agrees first multi-ecosystem partnership with Global Chair Partner Blacklyte

London, United Kingdom – June 12th, 2024 Esport entertainment company BLAST has announced a partnership with ergonomic peripheral manufacturer Blacklyte for the remainder of the 2024 Season, covering both the BLAST Premier and the BLAST Rainbow Six Esports titles.   Blacklyte comes onboard as the Official Gaming Chair Partner for BLAST Premier and BLAST Rainbow Six Esports. Blacklyte will supply their Athena X gaming chair to be used by competing professional players at the remaining events across 2024. Alongside physical chairs appearing at the remaining 2024 LAN events for BLAST

GR8 Tech Opens New Hub in Warsaw, Poland

An award-winning iGaming platform provider, GR8 Tech, opened its newest hub in Warsaw, Poland, on June 6, 2024. As a company committed to a remote-first model since the pandemic, GR8 Tech  continues to support its diverse international staff by offering flexible and comfortable working conditions. In addition to assisting in home office arrangements, the company also provides local hubs in target locations where employees are concentrated and hiring activities are underway.These hubs, available in several locations across Europe, including Cyprus, the Czech Republic, and,

Jumpgate AB announces outcome of the rights issue and decides on a directed share issue to guarantors

THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEELAND, SINGAPORE, SOUTH AFRICA, THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH SUCH ACTIONS, WHOLLY OR IN PART, WOULD BE UNLAWFUL. THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER TO BUY SECURITIES IN JUMPGATE AB. SEE ALSO IN THE SECTION "IMPORTANT INFORMATION" BELOW.The subscription period for Jumpgate AB's ("Jumpgate" or the "Company") rights issue with preferential rights for the Company's existing shareholders (the "Rights Issue"), which

Orkla announces the sale of Lilleborg

Orkla has entered into and completed an agreement to sell 100% of the shares in Lilleborg AS to Solenis, effective as of 12 June 2024. The transaction values Lilleborg at NOK 600 million on a cash and debt free basis.Lilleborg supplies professional cleaning solutions and is the market leader in the Norwegian B2B market. Lilleborg has since 2004 been the exclusive distributor for Diversey, a Solenis Company, in the Norwegian market, and offers, in addition, a wide portfolio of products and services. The company has more than 120 employees.   Solenis is a leading global producer of

STENOCARE is shortlisted for European Cannabis Company of the Year

STENOCARE A/SNASDAQ FIRST NORTH GROWTH MARKET, DENMARKTICKER:  STENO STENOCARE A/S (“Stenocare”) is honored to be recognized as one of the leading European Cannabis Companies in the industry annual award.Stenocare has been an active participant in the European medical cannabis industry since it was founded in 2017. The company has entered six different countries with prescription-based medical cannabis products and has been an active participant in developing these markets. Now, Stenocare has been nominated and shortlisted in the annual industry awards as one of the best European

Eevia Health publishes information memorandum regarding the rights issue

Eevia Health Plc, (”Eevia” or ”The Company”) publishes an information memorandum regarding the invitation to subscribe for shares in Eevia today. The information memorandum, including conditions and instructions for the rights issue, is available on the Company's website:  https://eeviahealth.com.The offer, if fully subscribed, is expected to provide Eevia with SEK 28.6 million before deduction of expenses related to the offer. The Rights Issue is secured through subscription commitments corresponding to approximately 10.8 percent of the offer volume, and guarantee commitments of

The paediatric diabetes study gets the green light to treat the age group 7 – 11 years

NextCell Pharma AB (publ) ("NextCell") announces that the Data Safety Monitoring Board for the ProTrans-Young study has recommended the principal investigator, Professor Per-Ola Carlsson, to continue with treatment of children in the younger age group 7 – 11 years. This decision is based on a review of all available safety data from the 36 children and adolescents who have participated in the study so far. The recruitment of the 30 children aged 7-11 will begin in August 2024.The first part of the ProTrans-Young study is a safety part (phase Ib) where all 6 patients aged 7-18 years are

Symplify Launches Dynamic Instant Messaging Module

Symplify, the Stockholm-based market leader in CRM and AI cloud solutions, is excited to announce the launch of its new Instant Messaging service, further enhancing its robust 360° communication platform.A core value of the Symplify journey is enabling seamless communication through powerful omnichannel capabilities. The already existing and effective mediums such as SMS, App Push, Email, and Print continue to generate long-term success for partners. Instant Messaging is the latest intuitive tool to join the service and it’s accessible from a single login, on a single platform. The new

NEW CORRECTION: Eevia Health publishes restated Interim Report Q1 2024

DUE TO TECHNICAL ERROR, THE SUMMARY OF FINANCIAL RESULTS WAS NOT UPDATED IN THE CORRECTION JUST RELEASED. THIS RELEASE HAS THE CORRECT SUMMARY OF UPDATED FINANCIAL FIGURES.Eevia Health Plc, (”Eevia” or ”The Company”) publishes restated Q1 2024 Interim report due to differences between the statutory Financial Statements for 2023 that was published Friday June 7 and the 2023 Year-end figures in the Interim Report Q1 2024 that was published on May 22, stemming from accounting adjustments agreed with the Company’s auditor.Following the annual audit and constructive discussions with our

The board of directors of G5 Entertainment utilizes authorization of repurchase of own ordinary shares

The board of directors of G5 Entertainment AB (publ) (the “Company” or “G5 Entertainment”) has resolved to initiate repurchase of ordinary shares through authorization by the Annual General Meeting in the Company on June 12, 2024. The purpose with the authorization is to provide the Board with greater possibilities to adapt the capital structure of the Company to the capital requirement from time to time and thus be able to contribute to increased shareholder value. In addition, the authorization intends to enable the board to transfer shares in connection with acquisitions of companies

Net Asset Value(s)

MITON UK MICROCAP TRUST PLC  Miton UK MicroCap Trust plc 12 June 2024 Miton UK Microcap Trust plc It is announced that at the close of business on 11th June 2024, the unaudited Net Asset Value per share of Miton UK Microcap Trust plc is: With the portfolio valued on a fair value basis: Including current period revenue to 11th June 2024                                                57.36p per ordinary share Excluding current period revenue                    57.19p per ordinary share Legal

There are no items matching the current filter
There are no more items matching the current filter
Back to top